Daussy C, Pied N, Wodrich H
Viruses. 2021; 13(7).
PMID: 34202573
PMC: 8310329.
DOI: 10.3390/v13071221.
Li J, Wang W, Wang J, Cao Y, Wang S, Zhao J
Front Oncol. 2021; 11:678226.
PMID: 34055646
PMC: 8155537.
DOI: 10.3389/fonc.2021.678226.
Amador C, Shah R, Ghiam S, Kramerov A, Ljubimov A
Curr Gene Ther. 2021; 22(2):104-131.
PMID: 33902406
PMC: 8531184.
DOI: 10.2174/1566523221666210423084233.
Rodrigues A, Fernandes P, Laske T, Castro R, Alves P, Genzel Y
Int J Mol Sci. 2020; 21(17).
PMID: 32854295
PMC: 7504089.
DOI: 10.3390/ijms21176111.
Zeng J, Meng X, Zhou P, Yin Z, Xie Q, Zou H
Arthritis Res Ther. 2019; 21(1):205.
PMID: 31481114
PMC: 6724270.
DOI: 10.1186/s13075-019-1985-9.
genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.
Lau C, Suh Y
F1000Res. 2018; 6:2153.
PMID: 29333255
PMC: 5749125.
DOI: 10.12688/f1000research.11243.1.
Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.
Fougeroux C, Holst P
Int J Mol Sci. 2017; 18(4).
PMID: 28420073
PMC: 5412272.
DOI: 10.3390/ijms18040686.
Adenoviral vector-based strategies against infectious disease and cancer.
Zhang C, Zhou D
Hum Vaccin Immunother. 2016; 12(8):2064-2074.
PMID: 27105067
PMC: 4994731.
DOI: 10.1080/21645515.2016.1165908.
Let There Be Light: Gene and Cell Therapy for Blindness.
Dalkara D, Goureau O, Marazova K, Sahel J
Hum Gene Ther. 2016; 27(2):134-47.
PMID: 26751519
PMC: 4779297.
DOI: 10.1089/hum.2015.147.
Adenoviral vector-mediated gene therapy for gliomas: coming of age.
Castro M, Candolfi M, Wilson T, Calinescu A, Paran C, Kamran N
Expert Opin Biol Ther. 2014; 14(9):1241-57.
PMID: 24773178
PMC: 4127140.
DOI: 10.1517/14712598.2014.915307.
A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
Zhou X, Zeng Y, Li J, Guo Y, Fu Y, He J
Virol J. 2013; 10:273.
PMID: 23987099
PMC: 3765914.
DOI: 10.1186/1743-422X-10-273.
Capsid-modified adenoviral vectors for improved muscle-directed gene therapy.
Guse K, Suzuki M, Sule G, Bertin T, Tyynismaa H, Ahola-Erkkila S
Hum Gene Ther. 2012; 23(10):1065-70.
PMID: 22888960
PMC: 3472516.
DOI: 10.1089/hum.2012.003.
Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.
Colella P, Auricchio A
Hum Gene Ther. 2012; 23(8):796-807.
PMID: 22734691
PMC: 3413895.
DOI: 10.1089/hum.2012.123.
In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector.
Kubo S, Kataoka M, Tateno C, Yoshizato K, Kawasaki Y, Kimura T
Hum Gene Ther. 2009; 21(1):40-50.
PMID: 19725756
PMC: 2829460.
DOI: 10.1089/hum.2009.027.
Gene therapy: regulations, ethics and its practicalities in liver disease.
Jin X, Yang Y, Li Y
World J Gastroenterol. 2008; 14(15):2303-7.
PMID: 18416454
PMC: 2705082.
DOI: 10.3748/wjg.14.2303.
Contrasting features of urea cycle disorders in human patients and knockout mouse models.
Deignan J, Cederbaum S, Grody W
Mol Genet Metab. 2007; 93(1):7-14.
PMID: 17933574
PMC: 2692509.
DOI: 10.1016/j.ymgme.2007.08.123.
Gene therapy for type 1 diabetes: is it ready for the clinic?.
DAnneo A, Rood P, Bottino R, Balamurugan A, He J, Giannoukakis N
Immunol Res. 2007; 36(1-3):83-9.
PMID: 17337769
DOI: 10.1385/IR:36:1:83.
In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.
Torres E, Monville C, Lowenstein P, Castro M, Dunnett S
Brain Res Mol Brain Res. 2005; 137(1-2):1-10.
PMID: 15950755
PMC: 2902248.
DOI: 10.1016/j.molbrainres.2004.10.046.
Inhibition and regression of atherosclerotic lesions.
Oka K, Chan L
Acta Biochim Pol. 2005; 52(2):311-9.
PMID: 15940346
PMC: 1360606.
Targeting site-specific chromosome integration.
Nuno-Gonzalez P, Chao H, Oka K
Acta Biochim Pol. 2005; 52(2):285-91.
PMID: 15940345
PMC: 1360607.